8(top 1%)
papers
238(top 1%)
citations
4(top 1%)
h-index
7(top 1%)
g-index
10
all documents
458
doc citations
204
citing journals
2
times ranked

Top Articles

#TitleJournalYearCitations
1Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemiaBlood2018170
2Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agentsBlood202352
3In VitroResponse to HBsAg of Peripheral Blood Lymphocytes from Recipients of Hepatitis B VaccineHepatology198422
4Phase 3 Randomized Study of Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) in Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) Ineligible for Transplant (ALCYONE)Blood201712
5Thin-layer chromatography of endotoxins, their derivatives and contaminantsJournal of Chromatography A19885
6Ustekinumab neutralizes human IL‐12 and IL‐23 mediated Th1 and Th17 cell function and provides clinical benefit to patients with plaque psoriasisFASEB Journal20081
715440 Cost-per-responder analysis of guselkumab versus secukinumab in obese patients using efficacy results from the ECLIPSE head-to-head clinical trialJournal of the American Academy of Dermatology20200
8Interim safety results of a global early access protocol (EAP) of abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) progressing after taxane-based chemotherapy.Journal of Clinical Oncology20130